星期五, 6月 10, 2016

哈佛CSSA 6/11辦端午節野餐詩歌音樂會

端午节野餐诗歌音乐会  
为纪念伟大的诗人屈原,哈佛大学中国学生学者联合会将在本周六(611日)举行一年一度的端午节野餐诗歌音乐会,时间是下午5点半--7点半。首先是节目表演,包括独慕诗剧屈原临江,诗词歌曲送友人,诗朗诵再别康桥,京剧彩唱红娘,京胡独奏迎春,小提琴独奏流浪者,黑管独奏茉莉花,等等,还有舞蹈和武术表演。表演者有波士顿大学音乐学院,哈佛大学查尔斯河管弦乐队,波士顿京剧社,黄河合唱乐团的艺术家们,和国际武术大赛金牌得主。表演之后是草地野餐--将备有汨罗江粽子,秭归茶卤蛋,湘西酸辣汤等屈原故地的风味食品,让大家品尝,让朋友们兼得精神和美食的享受! 

本次活动与当天的龙舟赛时间相连,地点也相近,朋友们可以在参加或观看了龙舟赛之后直接前往野餐音乐会。活动免费开放,但需要报名注册,欢迎热爱诗歌和音乐的朋友们参加--请点击链接注册,具体地点将随后通知。(婉谢未经邀请的媒体) 


波士頓龍舟節 6/12 大賽

轉載
6月12日著名音乐人冯丽丽将助阵第37届波士顿香港龙舟节

一年一度的波士顿香港龙舟节开始于1979年,是北美第一个,也是最久的龙舟节。它从一个社区活动发展成为新英格兰地区最大的亚裔文化庆祝活动,有超过2万人参加。

今年,第37届波士顿香港龙舟节将于612日(周日)在波士顿美丽的查尔斯河畔隆重举行。届时我们会看到64只龙舟的激烈角逐,其中包括来自麻州,罗德岛,纽约,南加州,加拿大多伦多等等优秀团队。在比赛进行的同时,还会有点睛仪式和近5个小时的文化艺术表演节目。

剑桥中国文化中心,剑桥中文学校的冯丽丽老师应邀主持表演节目部分,并献唱两首好听的歌曲“龙马精神”和“美极了"。
冯丽丽毕业于哈尔滨师范大学音乐系声乐专业和南非比勒陀利亚大学音乐教育专业!曾荣获第六届全国青年歌手电视大奖赛专业组通俗唱法荧屏奖,非洲华人歌唱比赛第一名等等国内外奖项, 为多部电视剧和电视晚会演唱主题歌,如电视连续剧都市大亨”“如烟旧事等等。具有多年舞台主持经验,在南非侨界主持、演唱、组织策划了多次大型文艺晚会,例如香港回归,澳门回归,国庆,春节及中国艺术团等等。

与国际知名音乐人Concord NkabindeWilson Joel,  Dennis East,  Rick wolffSteve Taylor, Steve Mac多次合作。 2009年在南非约翰内斯堡举办个人演唱会。2010年南非环球唱片(Universal Music)出版发行Lili Feng - “King Dong Love” (康定情歌)专辑,受到南非音乐界的瞩目和好评,并接受南非“The Star” SBAC2ETVSAfm 等电视台、电台及报社的专访。参加中国CCTV4与南非Mnet的联合录制的飞跃印度洋欢聚一堂大型晚会并演唱。
2009年, 她作为第一位在非洲出唱片的华人女歌手而被环球华网评为“2009年全球海外华人十大新闻人物,与骆家辉、高锟、赵美心等政界、教育界、商界名流同时获此殊荣。

20109月受邀上海世博会在非洲联合馆举办了为期一周的演唱专场,受到国内媒体的广泛关注和宣传。
2011年,作为特邀嘉宾在波斯瓦纳举办春节慈善演唱专场。同年5月,“Kang
Ding Love”专辑参选第17届南非音乐奖(SAMA).

2012年来美,现主持Lili唱歌工作室.
201510月,在北美枫香戏剧社的话剧海外剩女中担任音乐策划并演唱歌曲美极了
2016612日,受邀主持第37届波士顿龙舟节并演唱歌曲龙马精神”“美极了
201661819日,将参加话剧海外剩女外百老汇汇演,负责音乐兼演唱。冯丽丽同时在剑桥中文学校教授小主持人课程,在小篷车双语幼儿园教授音乐唱歌课。
冯丽丽是一位热爱公益的音乐人,她在非洲演唱会和CD的收入曾分别捐赠给非洲Amitofu关怀中心和博茨瓦纳红十字会。来美后,多次参加义演,如耆英老人会所,彩虹中心,波士顿国际儿童故事会,北美枫香戏剧社,剑桥中国文化中心等等。
冯丽丽希望在海外为宣扬中国民族音乐文化,促进中美文化交流尽自己的微薄之力。
(消息来源剑桥中国文化中心,本平台编缉董国贞)

******************************************
剑桥中国文化中心微信平台诚邀您投稿, 稿件内容关于华文教育,文化交流及社区动态。
投稿请联系: 董国贞 
微信帐号:dongguozhen11

 邮箱:idealproperty11@gmail.com

Brammer Bio Establishes Dedicated Late Phase Development and Commercial Manufacturing Facility for Advanced Cell and Gene Therapies in Lexington, Mass.

Brammer Bio Establishes Dedicated Late Phase Development and Commercial Manufacturing Facility for Advanced Cell and
Gene Therapies in Lexington, Mass.

50,000 square foot facility to be purpose built-out for manufacture of cell and gene therapies.

Brammer Bio is Manufacturing Personalized


BIO International, San Francisco, CA (USA) - Lexington, MA and Alachua, FL (USA) 
- June 8, 2016 - Brammer Bio, the best-in-class cell and gene therapy contract development and manufacturing organization, is proud to announce plans to build-out a 50,000 sq. ft. facility dedicated to late phase development, including Phase III and commercial production of viral vector-based and cell-based advanced therapies. The facility will be qualified and operational by Q2 of 2017.

“We’re delighted to bring to reality full scale gene and cell therapy production in Massachusetts to serve the needs of our clients,” Brammer Bio President and CEO Mark Bamforth said.  After completing a merger with Florida Biologix in March of 2016, the cell and gene therapy contract development and manufacturing organization (CDMO) will further solidify its leading technical and operational supply position through the build-out of the Lexington, MA, facility.

Massachusetts State Secretary of Housing and Economic Development, Jay Ash, was present at the announcement at BIO International, the large annual conference and exposition of the Biotechnology Industry Association being held in San Francisco and commented, “Massachusetts possesses a unique combination of assets that make us a world-leader in life sciences: unbeatable talent, a robust ecosystem and exceptional institutions. Brammer Bio will be right at home in the Commonwealth, adding their expertise to the mix of world-class companies that already call Massachusetts home," said Massachusetts Secretary of Housing and Economic Development Jay Ash.

“We welcome Brammer Bio to the growing life sciences manufacturing sector in Massachusetts,” said Travis McCready, President & CEO of the Massachusetts Life Sciences Center.  “Massachusetts is the global leader in the developing field of viral vector manufacuturing, and a state where life sciences products can come full cycle, through development, manufacturing, and commercialization.  We look forward to the opening of Brammer Bio’s new facility, and the increased manufacturing capacity it will add to our life sciences ecosystem in Massachusetts.


Brammer Bio is building on Florida Biologix’s ten-year track record of  manufacturing and testing to support clinical trials of advanced therapeutics. Florida Biologix was founded by Brammer Bio’s Chief Scientific Officer, Dr. Richard Snyder, who has gained unparalled expertise  through his 30 year career establishing cell and gene therapy manufacturing. The addition of largescale and latestage manufacturing at the Lexington, MA, facility, in conjunction with the early clinical focus of the Florida location, provides clients with the start-to-finish capability of manufacturing and testing advanced cell and gene therapies.

According to Dr. Snyder, “The Lexington facility will be equipped for largescale manufacturing with a focus on compliance in these emerging drug categories,  providing a reliable supply of high quality advanced therapies to our clients who are bringing their products to market.”

Brammer Bio is looking to grow the Lexington workforce by up to 200, employing engineers and scientists, along with specialists in jobs adding to the biotech industry’s growth in Massachusetts.

“We are excited to access the strong talent pool in Massachusetts and to work in close proximity with many of our clients as they develop cutting-edge therapies,” said Steve Kasok, Brammer Bio’s Chief Financial Officer.

By creating hightech jobs and establishing largescale manufacturing for novel cell and gene therapies, Brammer Bio is positioned to be a leading player in the supply of these new drugs. More than $50 million USD will be invested in the complete staffing and build-out of operations.

“On behalf of MassBio and its more than 750 member organizations, I am thrilled to welcome Brammer Bio to Massachusetts,” said Robert K. Coughlin, President & CEO of MassBio, the life sciences trade organization. “With the depth of experience from the Brammer leadership team and the company’s focus on developing and manufacturing the newest technologies, I know the Lexington facility will be a great addition to our worldleading life sciences cluster.”


Brammer Bio is focused on providing clinical and commercial supply of autologous and allogeneic cell therapies, and viral vector products for in vivo and ex vivo therapeutic applications, along with process and analytical development, and regulatory support enabling large pharma and biotech clients to accelerate the delivery of novel medicines and improve patient health.

賴銘琪會晤「東方辛德勒」何鳳山之女何曼禮

賴銘琪會晤「東方辛德勒」何鳳山之女何曼禮

10569

賴銘琪(左起)與何曼禮及其夫John B. Wood會晤,右為朱永昌組長
駐波士頓臺北經濟文化辦事處處長賴銘琪偕朱永昌組長於67日赴緬因州訪問,並會晤中華民國已故何鳳山大使之女何曼禮女士,就何大使於二次世界大戰期間簽發數以千計「生命簽證」,拯救奧地利猶太人脫離納粹屠殺暴行之義行,表達最高敬意。

賴處長表示,何大使二次大戰期間簽發「生命簽證」義行,舉世同欽,於去年獲得中華民國政府明令褒揚。2000年時,以色列政府也授予何大使最高榮譽「國際義人」(Righteous Among the Nations)稱號,並於2007年授予「榮譽公民」資格,深受肯定。

賴處長指出,何大使生前很少提及這段事蹟,為善不欲人知,直到逝世後才陸續為當年獲助的猶太人及他們的後人揭露,其人道主義的精神,是真正的英雄,世人的表率。駐波士頓臺北經濟文化辦事處樂於向本地各界介紹何大使義行,以廣週知。

何女士表示正在撰寫有關何大使義行之英文專書,賴處長允諾將於該書出版後向大波士頓及新英格蘭地區各界廣為推薦,讓世人共同認識這段有意義的史實。

何鳳山大使於1938年至1940年間擔任中華民國駐奧地利總領事期間,向當地的猶太人發放了數以千計「生命簽證」,使他們得以逃離納粹迫害,離開歐洲逃往他國。何大使於1997年過世後,其女何曼禮女士陸續蒐集其義行資料,並獲以色列與國際社會之一致推崇,譽為「東方辛德勒」,中華民國政府也於20159月在臺北明令褒揚,由何曼禮女士及夫婿吳約翰(John B. Wood)代表接受。(圖與文均由波士頓經文處提供)

CITY OF BOSTON ELECTIONS DEPARTMENT ASKS FOR FEEDBACK ON EARLY VOTING PLAN

CITY OF BOSTON ELECTIONS DEPARTMENT ASKS FOR FEEDBACK ON EARLY VOTING PLAN 

BOSTON - Thursday, June 9, 2016 - The City of Boston Election Department is asking residents for feedback on locations and timing of early voting locations. The public is encouraged to visitearlyvoting.boston.gov to provide input on their preferred locations and days/times for early voting. The survey will remain open until 5:00 p.m. on Thursday, June 16th. This feedback will be incorporated into the plan that will be recommended to the Election Commission for approval on July 6th, 2016.

"A democracy is only strong and vibrant when all residents are able to participate and make their voices heard," said Mayor Martin J. Walsh. "I am pleased that in Boston we are creating a plan that makes voting more accessible to all residents. City Hall is dedicated to fostering strong civic engagement and our early voting plan is another step forward."

The Early Voting Initiative will make participation in Election Day more convenient for all, particularly those with work schedules, family obligations or other obstacles. To promote access across the city, the Mayor's FY17 budget proposal commits $670,000 to meet and exceed the state requirement of having one early voting site open during normal business hours.

"Our objective is to further Mayor Martin J. Walsh's directive to give all of our residents an opportunity to participate in Boston's inaugural early voting period, and we value the input of all stakeholders towards developing a final plan," said Dion Irish, Commissioner of the Boston Election Department.

The Early Voting period runs from Monday October 24th to Friday November 4th at 5:00pm, and voters may cast their votes at any location. City Hall will be the main Early Voting location for in-person voting during that period, however voters may also vote early by mail application. For neighborhood locations, the Election Department requests input on the schedule and the most convenient times.

To provide public input, individuals should visit earlyvoting.boston.gov before 5:00 pm, June 16, 2016. Feedback can also be provided through the Boston Election Department's Facebook page, or@BostonElections on Twitter or via email at EVfeedback@boston.gov.

星期四, 6月 09, 2016

昆市道賓樓辦行人安全講座


Lieutenant Dan Minton of the Quincy Police, Betty Yau of the Mayor’s Office and Bonnie Kok of the Greater Boston Chinese Golden Age Center joined forces to hold a pedestrian safety workshop at The Tobin Towers at 80 Clay Street on Friday, June 3, 2016. Over 30 elder residents attended the workshop which was informative and interactive. The elders were eager to ask questions. Many learned the important rules particularly in crossing a four-lane street and the essence of safety. The workshop is co-sponsored by the Quincy Housing Authority and the South Shore Elder Services. Several similar workshops are being planned. A schedule with details will be announced soon. (From GBCGAC)
(丁慧明)於上週五2016年6月3日在昆士市Clay街80號的道賓樓老人屋合力舉辦了一個行人安全講座,約30多名耆英住客出席,講座具豐富資訊及非常互動,耆英們踴躍提問,尤其學習到如何正確地横過一條四線行車的馬路及注意安全的重要規則。這活動由昆士市房屋署及南岸老人局共同協辦。數個類似的講座正在計劃中,一經安排妥當,即將公佈講座的時間與細節。(中華耆英會提供)
Front row - 3rd from right:
Lieutenant Dan Minton, Quincy Police Dept.; Betty Yau, Quincy Mayor’s Office and Bonnie Kok, Greater Boston Chinese Golden Age Center
前排右第3人:昆士市警官明頓(Lt. Dan Minton), 昆士市市長辦公室Betty Yau (邱潔芳) ,耆英會及南岸老人局 Bonnie Kok(丁慧明 ) 。

MAYOR MARTIN J. WALSH ANNOUNCES HUNTINGTON THEATRE COMPANY’S MAINSTAGE WILL REMAIN ON HUNTINGTON AVENUE, THE AVENUE OF THE ARTS

MAYOR MARTIN J. WALSH ANNOUNCES HUNTINGTON THEATRE COMPANY’S MAINSTAGE WILL REMAIN ON HUNTINGTON AVENUE, THE AVENUE OF THE ARTS


(BOSTON, MA)  Mayor Martin J. Walsh joined Huntington Managing Director Michael Maso and developer John Matteson of QMG Huntington, LLC to announce a partnership that will allow the Huntington Theatre Company to stay in its current home, the Boston University Theatre.

On Thursday afternoon, Mayor Walsh declared, “The Huntington Theatre Company is here to stay, on Huntington Avenue where it belongs. From the very beginning we have been committed to bringing the key players to the table in order to maintain the Huntington’s home on the Avenue of the Arts.”

Over 200 people attended the press conference, including Huntington Artistic Director Peter DuBois, Huntington Board Chairman Carol G. Deane, incoming Huntington Board Chairman David Epstein, incoming Huntington Board President Sharon Malt, Chief of Economic Development John Barros, Chief of Arts and Culture Julie Burros, and Chief of Policy Joyce Linehan, who joined Mayor Walsh on stage.

In his speech, Mayor Walsh said, “The theatre’s legacy is rich and diverse, from its commitment to the works of famed African American playwright August Wilson, to its innovative partnership with Codman Academy Charter Public School. The Huntington is one of Boston’s great cultural treasures. I am thankful for the shared commitment of John Matteson and his team to our goals, and I look forward to the bright future of this theatre.”
https://lh5.googleusercontent.com/UJJXiduDcDw5JoCGdAT9nKkwg7JIjWUKCtcteMRuLCLPjYa2TAsyIHrObnXBR_el69wt_ISpcDV3gfycSJQuRDq_AnAIui9gHpcnE2yHEhyu73vjZKdRbcNj6jX8oDIngfatTKii
Michael Maso said, “We are deeply grateful to Mayor Walsh and his administration for their essential role in helping find a solution which will allow the Huntington to not only continue to produce ambitious, large-scale works in a renovated and expanded Huntington Avenue theatre, but also to expand and enhance our services to audience members, young people, our neighborhood, and the theatre community of Boston.”

Following Maso, John Matteson of QMG Huntington, LLC said, “We would like to thank Mayor Walsh, his staff and the BRA for their guidance through this process. We look forward to a long relationship with the Avenue of the Arts and the new Huntington.”

“The Fenway community is so appreciative of the Mayor and his team's accomplishment in keeping the Huntington Theatre Company on the Avenue of the Arts in the Fenway Cultural District," said Kelly Brilliant, Executive Director of the Fenway Alliance, Inc. “The Huntington is a backbone not only for a dedicated, engaged arts audience in Boston, but is also a tangible presence, and intellectual and emotional touchstone in our community — the Fenway.  On so many nights and afternoons, the theatre is a buzzing gathering place in the Fenway Cultural District.  A great neighbor who welcomes us all, lifts our spirits and challenges our minds with fresh ideas and diverse perspectives — all in the form of powerful art.”

“Having long-term control over our mainstage theatre on a year-round basis is a huge step for the Huntington,” said Artistic Director Peter DuBois. “It means that we can explore additional artistic programming and partnerships throughout the year, and ensures that the Huntington can nurture future generations of theatre artists and arts organizations.”

Mayor Walsh ended with saying, “This is an exciting day, not just for the Huntington. This is an exciting day for the entire city of Boston.”

The Huntington is a local economic driver in the City of Boston, employing over 400 staff members and artists and generating more than $19 million annually in economic activity. Through its education programs, the Huntington provides programs for more than 33,000 youth and community members annually, many of them from Boston’s neighborhoods.

In October 2015, Boston University and the Huntington announced that they would dissolve their 33-year partnership in June 2017, and the BU Theatre complex would be sold on the open market. A local development company, QMG Huntington LLC, led by John Matteson, purchased the BU Theatre complex in May 2016. Thanks to the direct support of Mayor Walsh and his administration, the Huntington and QMG have now agreed:

·         The Huntington will gain exclusive control of the historic theatre itself and the service wing to its west, which it plans to fully renovate at its own expense;
·         The Huntington will expand its lobbies and other public spaces amenities into new shell and core space to be provided by QMG;
·         QMG will develop the properties that now hold the Huntington’s production center, and the Huntington will relocate its scenic, paint, and prop shops in order to another location.
More details will emerge in the coming months as the design and review process of the development is finalized, and in order to succeed the Huntington will embark on a major new capital fundraising campaign.  

The City of Boston is currently leading Boston Creates, Boston's cultural planning process, designed to create a long-term plan to prioritize, coordinate, and align public and private resources to strengthen cultural vitality in the City. Over the past year, the Boston Creates team undertook an extensive community engagement, holding three town halls, 118 community conversations, more than 80 focus groups and meetings, an online creative engagement participation survey and a crowd-sourced mapping of cultural assets. Using the data obtained through the process, the team worked closely with the Boston Creates Steering Committee and Leadership Council to develop a draft planfor public feedback. The final plan will be released this summer.

French-based ‘Live Biotherapeutic’ Company Biose to open their first US office in Cambridge


French-based ‘Live Biotherapeutic’ Company Biose to open their first US office in Cambridge
Announcement comes during 2016 BIO International Convention in San Francisco

Maxence Desjonquères (far left), CEO of Biose, meets with Massachusetts life sciences and economic development leaders in the Massachusetts Pavilion at the BIO 2016 Convention in San Francisco, including (from left to right) Travis McCready, President & CEO of the Massachusetts Life Sciences Center, Lisa Hemmerle, Director of Economic Development for the City of Cambridge, Pamela Norton, Vice President for Industry Relations & Programs at the Massachusetts Life Sciences Center, and Jay Ash, Massachusetts Secretary for Housing & Economic Development.  Not pictured but participating in the meeting was MassBio President & CEO Bob Coughlin.
San Francisco, CA - BIOSE®, a French pharmaceutical company, the Massachusetts Life Sciences Center, and MassBio announced today that BIOSE® is opening their first US office in Cambridge, Massachusetts at the Cambridge Innovation Center.  BIOSE®’s mission is to design and market the best live biotherapeutic products to improve human health. Their Massachusetts office will primarily focus on licensing activities.

BIOSE® has spent the past 50 years working in the Gynecology, Infectology and Gastroenterology sectors in Europe, South America and South-East Asia. BIOSE® has clinical proof of concept in multiple therapeutic areas and a microbiota-centered pipeline, containing as of today more than 15 therapeutic projects in areas including clostridium difficile infection, necrotizing enterocolitis, metformin associated diarrhea and recurrent vulvovaginal candidiasis, for which they have reached human proof of concept and are ready for licensing.

“The life sciences cluster continues to grow in Massachusetts, and we are excited to welcome Biose into the fold,” said Governor Charlie Baker. “The increasing number of global companies making Massachusetts their U.S. headquarters is a testament to the strength of the ecosystem we have built, the unbeatable talent and the bright future of life sciences in the Commonwealth.”

“When we decided to open a subsidiary in the US, the Boston area was a clear choice for us,” said Maxence Desjonquères, CEO of Biose.  “From a business perspective it is one of the leaders worldwide for the biotech and pharmaceutical industry, with all of the potential partners we need to develop and advance our R&D projects.  On a practical point, the Boston area is the best place to be in the US while staying connected with Europe.  With only a 7 hour flight and a manageable time difference with France, our French team and American team will be easily able to work together!”

“We welcome Biose to Massachusetts and look forward to the contributions they will make here to the growing field of microbiota-related therapeutics,” said Travis McCready, president & CEO of the Massachusetts Life Sciences Center. “Biose will join a growing pool of companies and researchers that are working in this exciting space in Massachusetts.”

“We are thrilled to welcome Biose to Massachusetts and we congratulate them on establishing their first US office in Cambridge,” said Robert K. Coughlin, President & CEO of MassBio. “We know that Biose will bring value to and benefit from our robust life sciences community as they continue to grow and connect with new partners.”

“We are so excited to welcome Biose to Cambridge, the Life Sciences Corridor, and the Commonwealth,” said Lisa Hemmerle, Director of Economic Development for the City of Cambridge.  “It is companies like Biose that continue to make this area a world-leading life sciences ecosystem.”